Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Astrana Health (ASTH)
NASDAQ:ASTH
Holding ASTH?
Track your performance easily
ASTH Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$33.44 - $63.20
Previous Close$33.7
Volume1.05M
Average Volume (3M)298.40K
Market Cap
$1.66B
Enterprise Value$1.79B
Total Cash (Recent Filing)$350.35M
Total Debt (Recent Filing)$475.82M
Price to Earnings (P/E)25.8
Beta1.31
Next Earnings
Feb 20, 2025EPS Estimate
$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.30
Shares Outstanding56,252,730
10 Day Avg. Volume266,837
30 Day Avg. Volume298,398
Standard Deviation0.19
R-Squared0.09
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)2.69
Price to Sales (P/S)1.10
Price to Cash Flow (P/CF)14.00
P/FCF Ratio15.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.04
Enterprise Value/Gross Profit8.31
Enterprise Value/Ebitda13.60
Forecast
1Y Price Target
$65.43Price Target Upside94.15% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Astrana Health News
PremiumCompany Announcements
Astrana Health to Share Financial Insights at Conferences
PremiumCompany Announcements
Astrana Health Grants Equity Awards to Key Executives
PremiumCompany Announcements
Astrana Health Acquires Prospect Health for $745 Million
Bulls Say, Bears Say
Bulls Say
Acquisitions And ExpansionThe acquisition of Prospect’s Medical Group strengthens Astrana's positioning in California and adds momentum to the company's full-risk conversion strategy, enhancing its long-term growth narrative.
Financial PerformanceManagement projects over 25% revenue growth and more than 10% EBITDA margins to continue, demonstrating strong financial health and operational efficacy.
Strategic InitiativesAstrana's strategy focuses on entering new markets with potential to become a 'top 3' platform through strategic deals and partnerships, showcasing a proactive approach to market leadership.
Bears Say
Expansion And AcquisitionsExpansion into new markets and large acquisitions create margin headwind amidst industry-wide challenges.
Financial PerformanceASTH provided expectations of the financial impact of the CHS acquisition, including an expected $4m negative EBITDA impact in 4Q24.
Medicaid And Risk ExposureASTH takes on almost double the actuarial medical expense exposure vs. partial risk members in the pursuit of converting members to full risk.
---
Ownership Overview
39.46% Insiders
16.00% Mutual Funds
8.19% Other Institutional Investors
13.65% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ASTH FAQ
What was Astrana Health’s price range in the past 12 months?
Astrana Health lowest stock price was $33.44 and its highest was $63.20 in the past 12 months.
What is Astrana Health’s market cap?
Currently, no data Available
When is Astrana Health’s upcoming earnings report date?
Astrana Health’s upcoming earnings report date is Feb 20, 2025 which is in 60 days.
How were Astrana Health’s earnings last quarter?
Astrana Health released its earnings results on Nov 07, 2024. The company reported $0.33 earnings per share for the quarter, beating the consensus estimate of $0.309 by $0.021.
Is Astrana Health overvalued?
According to Wall Street analysts Astrana Health’s price is currently Undervalued.
Does Astrana Health pay dividends?
Astrana Health does not currently pay dividends.
What is Astrana Health’s EPS estimate?
Astrana Health’s EPS estimate is $0.1.
How many shares outstanding does Astrana Health have?
Astrana Health has 49,120,033 shares outstanding.
What happened to Astrana Health’s price movement after its last earnings report?
Astrana Health reported an EPS of $0.33 in its last earnings report, beating expectations of $0.309. Following the earnings report the stock price went down -20.515%.
Which hedge fund is a major shareholder of Astrana Health?
Among the largest hedge funds holding Astrana Health’s share is Woodline Partners LP. It holds Astrana Health’s shares valued at 11M.
---
Astrana Health Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$65.43 (94.15% Upside)
$65.43 (94.15% Upside)
Hedge Fund Trend
Increased
By 203.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 4.7%
Last 30 Days ▼ 4.1%
Last 30 Days ▼ 4.1%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-6.69%
12-Months-Change
Fundamentals
Return on Equity
9.62%
Trailing 12-Months
Asset Growth
19.76%
Trailing 12-Months
Company Description
Astrana Health
Apollo Medical Holdings, Inc. engages in the provision of healthcare services. It offers integrated care, inpatient, and physician alignment solutions. The company focuses on physicians providing medical care, population health management and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The firm operates through the healthcare delivery segment. The healthcare delivery segment implements and operates innovative health care models to create a patient-centered, physician-centric experience. Apollo Medical Holdings was founded on November 1, 1985 and is headquartered in Alhambra, CA.
---
ASTH Company Deck
---
ASTH Earnings Call
Q3 2024
0:00 / 0:00
---
ASTH Stock 12 Month Forecast
Average Price Target
$65.43
▲(94.15% Upside)
Technical Analysis
Best Analysts Covering ASTH
1 Year
1 Year Success Rate
2/6 ratings generated profit
1 Year Average Return
+14.07%
reiterated a buy rating 3 months ago
Copying David Larsen's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +14.07% per trade.
---